Kura Oncology, Inc. (KURA) › Net IncomeKura Oncology, Inc. (KURA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2007: -$15.0K2008: -$33.6K2009: -$20.0K2010: -$22.4K2011: -$27.0K2012: -$27.3K2013: -$28.6K2015: -$22.62M2016: -$27.56M2017: -$35.43M2018: -$60.45M2019: -$63.14M2020: -$89.62M2021: -$130.47M2022: -$135.84M2023: -$152.63M2024: -$173.98M2025: -$278.67M-$278.67M2007Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$278.67M-60.2%2024-$173.98M-14.0%2023-$152.63M-12.4%2022-$135.84M-4.1%2021-$130.47M-45.6%2020-$89.62M-41.9%2019-$63.14M-4.5%2018-$60.45M-70.6%2017-$35.43M-28.6%2016-$27.56M-21.8%2015-$22.62M—2013-$28.6K-4.7%2012-$27.3K-1.0%2011-$27.0K-20.7%2010-$22.4K-12.0%2009-$20.0K+40.5%2008-$33.6K-124.5%2007-$15.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share